@inproceedings{inproceedings, title  = {{Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 × CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2018-99-111539 }},

 year = {{2018}},

 month = {{11}},

 author = {{Rutella S and Church SE and Vadakekolathu J and Viboch E and Sullivan AH and Hood T and Warren SE and Cesano A and La Motte-Mohs R and Muth J and Lelièvre H et al}},

 doi = {{10.1182/blood-2018-99-111539}},

 volume = {{132}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{444-444}},

 note = {{Accessed on 2026/02/25}}}